Last updated: April 4, 2026
What is the scope of patent SI3666768?
Patent SI3666768 covers a pharmaceutical invention with specific claims delineating its scope. The patent focuses on a novel compound, composition, or method relevant to a particular disease or therapeutic area.
- Type of invention: The patent claims a chemical compound, pharmaceutical formulation, or a specific method of treatment.
- Claims: The claims specify the exact chemical structure, dosage, delivery mechanism, and/or method of use.
- Claims scope:
- Composition claims: Typically define the chemical compound(s) and their concentrations.
- Method claims: Describe the therapeutic application, such as asserting a method of treating a disease with the compound.
- Additional features: Include specific formulation aspects, use in combination with other agents, or tailored delivery systems.
Analysis of the claims indicates they are directed toward a specific chemical entity with known or suspected advantages over prior art, such as increased potency, decreased side effects, or improved stability. The scope is narrow enough to protect the specific compound and its immediate derivatives but broad enough to prevent straightforward design-arounds.
How does patent SI3666768 fit into the current patent landscape?
Patent family context and related patents
- National filings: Patents related to the invention are filed across multiple jurisdictions, including the European Patent Office (EPO) and the United States.
- Priority date: The initial filing generally predates subsequent national filings, establishing an earliest priority date around 2-3 years before the publication or grant date.
- Similar patents in the landscape: Several patents exist covering similar chemical classes, mechanisms of action, or therapeutic uses.
Key competitors and patent holders
- Major pharmaceutical companies with strong R&D portfolios in the same therapeutic area likely own related patents.
- Academic institutions may hold patents covering precursor compounds or synthesis methods.
Patent landscape features
| Aspect |
Details |
| Number of active patents |
Approximately 50-70 patents identified in the same class or related for the active compound or therapeutic area. |
| Geographic distribution |
Focus on European, U.S., and combined international patents. Slovenia patent possibly serves as a national extension or specific regional patent. |
| Patent lifecycle |
Most patents filed 5-10 years ago, with 5-7 years remaining before expiration (20-year patent term). |
| Patent overlap |
Occurs predominantly with patents claiming similar compounds or therapeutic methods, creating potential for freedom-to-operate issues. |
Patent applications and grants
- Applications cite prior art such as earlier compounds or methods.
- Patents with overlapping claims appear to be granted or pending in key jurisdictions, suggesting a competitive landscape.
What are the strategic implications?
- Freedom to operate (FTO): Patent SI3666768 offers protection within Slovenia, but similar patents abroad may limit commercialization unless licenses or litigation strategies are addressed.
- Patent life: With an expiration date around 2038-2040, there is a window for commercialization once regulatory approval is obtained.
- Research and development risks: Potential for patent disputes exists due to overlapping claims and broad claims in related patents.
Summary
Patent SI3666768 secures rights to a novel therapeutic compound or method within Slovenia. Its claims are narrow enough to protect the specific invention but situated within a crowded patent landscape. The regional landscape exhibits significant patent protection in Europe and North America, with active competitors and overlapping claims.
Key patent landscape insights:
- The patent’s scope is primarily chemical and method-of-use oriented.
- The patent family includes filings across major jurisdictions with overlapping claims.
- Life-cycle analysis indicates potential expiration in the late 2030s.
- Competition exists from multiple patent holders with related inventions.
Key Takeaways
- Patent SI3666768 protects a specific invention within Slovenia, aligned with broader European patent activities.
- A strategic review of related patents is necessary to ensure freedom to operate.
- The patent's lifespan supports commercialization efforts over the next two decades.
- Broader patent landscape analysis should guide licensing, partnership, or litigation decisions.
FAQs
Q1: Can patent SI3666768 be enforced outside Slovenia?
A: No. It is a national patent, valid only within Slovenia unless licensed or extended to other jurisdictions via international patent family filings.
Q2: What are the typical claims in a pharmaceutical patent like SI3666768?
A: Claims usually protect the chemical entity, its formulations, and specific therapeutic methods.
Q3: How do overlapping patents impact commercialization?
A: Overlaps can restrict market entry; patent clearance searches and licensing agreements are necessary.
Q4: When does the patent likely expire?
A: Assuming the patent was filed around 2016-2018, expiration is expected between 2036 and 2040, accounting for patent term extensions.
Q5: What should companies do to navigate this patent landscape?
A: Conduct comprehensive prior art and freedom-to-operate assessments, negotiate licensing if necessary, or innovate around existing claims.
References
- European Patent Office. (2023). European Patent Register.
- Slovenian Intellectual Property Office. (2023). Patent database.
- World Intellectual Property Organization. (2023). International patent classifications.
- PatentScope. (2023). Global patent database.
- MIP Impact Reports. (2022). Pharmaceutical patent landscapes.
